Status:
UNKNOWN
Evaluation of the Effect of Anatolian Propolis on Covid-19 in Healthcare Professionals
Lead Sponsor:
Ataturk University
Conditions:
Covid19
Eligibility:
All Genders
18-65 years
Brief Summary
There is no prophylaxis for people at high risk of developing COVID-19. It is one of the first clinical studies aiming to investigate the effect of Anatolian Propolis against COVID-19. This study will...
Detailed Description
Severe Acute Respiratory Syndrome Coronavirus - 2 (SARS-CoV-2) caused by Covid-19 epidemics have been implicated in 330,000 more than cases in Turkey and 40 health workers at a rate close to 5% by tho...
Eligibility Criteria
Inclusion
- 18 years and over,
- Not having had COVID-19 (diagnosed by PCR)
- Symptom that may be associated with COVID-19 for the past 14 days (fever, fatigue, loss of taste and smell)
- No additional chronic disease (such as chronic heart lung)
- Healthcare workers (doctor, nurse, medical secretary)
- Working in an emergency medicine clinic
- Being a volunteer
Exclusion
- Not being willing to participate in research
- Patients younger than 18 years old,
- Pregnant patients
- Immunosuppressive patients
- Patients receiving chemotherapy for any reason
- Being appointed to another clinic from the emergency medicine clinic within a 1-month period planned as a working period
- Propolis allergy or history of hypersensitivity to any of its ingredients.
- Volunteers taking a break from drug use during the study
Key Trial Info
Start Date :
December 25 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 25 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04680819
Start Date
December 25 2020
End Date
January 25 2021
Last Update
December 23 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.